- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05198089
Development of a Digital Tool, MyInspiration, for the Improvement of Spiritual Well-Being in Patients With Cancer
July 11, 2023 updated by: Timothy Pawlik, Ohio State University Comprehensive Cancer Center
The Development and Pilot of MyInSPO: An Individualized Spirituality Program for Oncology Patients to Improve Spiritual Well-Being
The purpose of this study is to pilot a beta version of a digital resource that supports the religious and spiritual beliefs of cancer patients, "MyInspiration".After receiving a cancer diagnosis, survivors are encouraged to make major life-altering decisions related to their treatment and care.
The availability of spiritual/religious resources during cancer treatment may positively impact patient outcomes, feelings of well-being, and be essential components of holistic, patient-centered care.
MyInspiration is a digital tool focused on spiritual and/or religious guidance and support that can be customized based on patient preferences and administered to cancer patients and their family members during cancer treatment.
MyInspiration may help improve spiritual well-being in patients with cancer.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVES:
I. Conduct a pilot of MyInspiration to determine acceptability, feasibility, and general satisfaction by its end-users.
II. Explore the qualitative opinions of patients who participated in the feasibility trial more in-depth using 1-on-1 interviews.
OUTLINE: Single-group feasibility pilot.
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Ohio State University Comprehensive Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- > 18 years of age
- Capacity to sign an informed consent form
- Eligible for a surgical procedure (defined with International Classification of Diseases [ICD]-10 codes) that will require an in-patient stay at the Ohio State University Comprehensive Cancer Center (OSUCCC)-James
- Diagnosed with cancer
- Ability to read English (however, we will make all possible considerations to include non-native English speakers)
- Access to some form of internet (webpage, smartphone, tablet, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm I (MyInspiration)
Patients use MyInspiration for spiritual and/or religious guidance for 30 days.
|
Use MyInspiration website
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of MyInspiration:Recruitment
Time Frame: Up to 30 days
|
Feasibility will be assessed by ratio of patients that enroll of the patients that indicate interest in the study
|
Up to 30 days
|
Feasibility of MyInspiration:Data Collection
Time Frame: Up to 30 days
|
Feasibility will be assessed by completion rates of both the baseline and follow-up measures
|
Up to 30 days
|
Feasibility of MyInspiration:Usage Patterns
Time Frame: Up to 30 days
|
Feasibility will be assessed by meta-analytics of website usage.
|
Up to 30 days
|
Acceptability of MyInspiration
Time Frame: Up to 30 days
|
Acceptability will be assessed by study attrition rates.
|
Up to 30 days
|
General satisfaction of MyInspiration
Time Frame: Up to 30 days
|
General Satisfaction will be assessed using an investigator-created 6-item scale assessing participants experience with MyInspo overall and its specific components
|
Up to 30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Decisional regret
Time Frame: Up to 30 days
|
Decisional regret will be assessed post cancer-directed surgery using The Decisional Regret Scale.Items will also be adapted from scales developed by Clark et al. regarding the perceptions of one's treatment decisions, their outcomes, and the inherent uncertainty of decision making and cancer control.
|
Up to 30 days
|
Spiritual well-being
Time Frame: Up to 30 days
|
Spiritual well-being will be assessed using the Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being, the Meaning of Cancer Subscale from the Impact of Cancer scale, and 1-item assessing spiritual distress.
The Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being is a 12-item scale with a minimum score of 0 and a maximum score of 48; higher scores indicate a greater sense of spiritual well-being.
|
Up to 30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Timothy M Pawlik, MD, Ohio State University Comprehensive Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2022
Primary Completion (Estimated)
December 31, 2023
Study Completion (Estimated)
December 31, 2023
Study Registration Dates
First Submitted
December 20, 2021
First Submitted That Met QC Criteria
January 14, 2022
First Posted (Actual)
January 20, 2022
Study Record Updates
Last Update Posted (Actual)
July 12, 2023
Last Update Submitted That Met QC Criteria
July 11, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- OSU-20390
- NCI-2021-00630 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Solid Neoplasm
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingRefractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingRefractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States, Canada
-
National Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterTerminatedLocally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)RecruitingLocally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States, Puerto Rico
-
University of California, San FranciscoCompletedIntegrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced CancerAdvanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
Clinical Trials on Internet-Based Intervention
-
Anadolu UniversityNot yet recruitingMental Health Issue
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); University of Alabama at Birmingham; Oregon...RecruitingProstate CarcinomaUnited States
-
Anadolu UniversityEskisehir Osmangazi UniversityNot yet recruiting
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Terminated
-
Rhode Island HospitalNational Cancer Institute (NCI)UnknownMelanoma (Skin) | Non-melanomatous Skin CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); University of VirginiaRecruitingBreast Cancer FemaleUnited States
-
Catholic University of the Sacred HeartKarolinska Institutet; Linkoeping University; Istituto Auxologico Italiano; Bar-Ilan...Not yet recruiting
-
Anadolu UniversityNot yet recruitingMental Health Issue
-
Coordinación de Investigación en Salud, MexicoUniversidad Nacional Autonoma de Mexico; Hospital Infantil de Mexico Federico...Completed
-
Per TornvallUppsala University; Mid Sweden UniversityRecruiting